The GvHD Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy

Gastrointestinal graft-versus-host disease increases the risk of post-engraftment bloodstream infections

Jul 13, 2018

Yasuo Morifrom Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan, and colleagues conducted a retrospective study to evaluate the etiology, morbidity, outcomes, and risk factors of bloodstream infection (BSI) in patients undergoing allogeneic hematopoietic stem cell transplantation (allo-HSCT). The study was published ahead of print in Biology of Bone and Marrow Transplantation.

Patients and methods:

  • N = 346 patients
  • Median age = 49 years (16–72)
  • Allo-HSCT: between July 2009 and December 2016

Key findings:

  • Post-engraftment period BSI (PE-BSI): 43/316 (13.6%)
    • 30 patients had one PE-BSI episode
    • 12 patients had two episodes
    • One patient had three episodes
  • The median onset of first PE-BSI: 65 days (18–154) after transplant
  • 62 pathogens were identified: gram-positive bacteria, gram-negative bacteria, and fungi: 54.8% vs5% vs9.7%
  • Incidence of acute GvHD (grade II to IV) in patients with and without PE-BSI: 36/43 (83.7%) vs112/273 (41.0%), P< 0.0001
  • Risk factors for PE-BSI:
    • Acute gastrointestinal (GI) GvHD: odds ratio (OR) = 8.82 (95% CI, 3.99–5), P< 0.0001
    • Methylprednisolone usage as GvHD prophylaxis: OR = 6.49 (95% CI, 1.49–2), P= 0.013
  • 3-year overall survival in patients with PE-BSI compared with those without PE-BSI: 47.0% vs6%, P< 0.001

Taken together, this study indicates that GI-GvHD increases the risk of post-engraftment blood stream infections. The authors suggested that “microbiological monitoring for BSIs and minimizing intestinal dysbiosis may be crucial to break the vicious cycle between GI-GvHD and bacteremia, consequently improve transplant outcomes especially in patients who require additional immunosuppressants.” Providing therapy with novel agents and supportive care for subsequent PE-BSI may improve outcomes and reduce therapy-related mortality.

  1. Mori Y . et al. Gastrointestinal graft-versus-host disease is a risk factor for post-engraftment blood stream infection in allogeneic hematopoietic stem cell transplant recipients. Biol Blood Marrow Transplant.2018 Jun 14. DOI: 10.1016/j.bbmt.2018.06.002. [Epub ahead of print].